ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,450, issued on Jan. 27, was assigned to Aligos Therapeutics Inc. (South San Francisco, Calif.).
"Methods and compositions for targeting PD-L1" was invented by Tongfei Wu (Boortmeerbeek, Belgium), Pierre Jean-Marie Bernard Raboisson (Wavre, Belgium), Francois Gonzalvez (Antwerp, Belgium), Antitsa Dimitrova Stoycheva (Half Moon Bay, Calif.), Cheng Liu (Burlingame, Calif.), Jerome Deval (Pacifica, Calif.) and David McGowan (Brussels).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds that can be useful as inhibitors of PD-1, PD-L1 or the PD-1/PD-L1 interaction. Also provided herein are pharmaceutical compositions of a compound ...